Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Off-label use of alitretinoin].

Literature DB >> 24150823

[Off-label use of alitretinoin].

K Fritz¹, G S Tiplica, C Salavastru, M Onder.

Abstract

Oral alitretinoin (9-cis retinoic acid) is an endogenous retinoid related to vitamin A. Studies have shown that oral alitretinoin is effective and well-tolerated in the treatment of severe chronic hand eczema, so that it is approved for this indication. This review summarizes new studies and clinical experience on the off-label use of alitretinoin.

Entities: Chemical Disease

Mesh：

Substances：

Year: 2013 PMID： 24150823 DOI： 10.1007/s00105-013-2593-2

Source DB: PubMed Journal: Hautarzt ISSN： 0017-8470 Impact factor: 0.751

35 in total

Review 1. Keratitis-ichthyosis-deafness syndrome: response to alitretinoin and review of literature.

Authors: Siegfried Werchau; Ferdinand Toberer; Alexander Enk; Peter Helmbold
Journal: Arch Dermatol Date: 2011-08

2. Treatment of atopic eczema with oral alitretinoin.

Authors: M Grahovac; S Molin; J C Prinz; T Ruzicka; A Wollenberg
Journal: Br J Dermatol Date: 2009-11-03 Impact factor: 9.302

3. Successful treatment with oral alitretinoin in women of childbearing potential with Darier's disease.

Authors: M Zamiri; C S Munro
Journal: Br J Dermatol Date: 2013-09 Impact factor: 9.302

4. Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoaging.

Authors: Leslie Baumann; Justin Vujevich; Monica Halem; Lucy K Martin; Francisco Kerdel; Melissa Lazarus; Heather Pacheco; Laura Black; Joy Bryde
Journal: Cutis Date: 2005-07

Review 5. Differentiating agents in the treatment of leukemia.

Authors: L Degos
Journal: Leuk Res Date: 1990 Impact factor: 3.156

Review 6. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials.

Authors: K Chen; J C Craig; S Shumack
Journal: Br J Dermatol Date: 2005-03 Impact factor: 9.302

[Off-label use of alitretinoin].

Review 1. Keratitis-ichthyosis-deafness syndrome: response to alitretinoin and review of literature.

2. Treatment of atopic eczema with oral alitretinoin.

3. Successful treatment with oral alitretinoin in women of childbearing potential with Darier's disease.

4. Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoaging.

Review 5. Differentiating agents in the treatment of leukemia.

Review 6. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials.

7. 9-cis-retinoic acid treatment increases serum concentrations of alpha-tocopherol in former smokers.

8. Successful treatment of palmoplantar hyperkeratotic psoriasis with a combination of etanercept and alitretinoin.

Review 9. Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer.

10. Alitretinoin--its use in intractable hand eczema and other potential indications.

Review 1. Stem Cells as Target for Prostate cancer Therapy: Opportunities and Challenges.